Similar articles for PMID: 20185966

Year	Number of Results
1993	1
1994	2
1996	2
1999	4
2000	5
2001	6
2002	9
2003	13
2004	10
2005	17
2006	12
2007	12
2008	13
2009	10
2010	21
2011	28
2012	23
2013	18
2014	12
2015	12
2016	10
2017	9
2018	7
2019	3
2020	5
2021	1
2022	7
2024	0

1

Real-time RT-PCR analysis for evaluating the Her2/neu status in breast cancer.

Cuadros M, Talavera P, López FJ, García-Peréz I, Blanco A, Concha A. Cuadros M, et al. Pathobiology. 2010;77(1):38-45. doi: 10.1159/000272953. Epub 2010 Feb 25. Pathobiology. 2010. PMID: 20185966 Free article.

2

Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.

Vinatzer U, Dampier B, Streubel B, Pacher M, Seewald MJ, Stratowa C, Kaserer K, Schreiber M. Vinatzer U, et al. Clin Cancer Res. 2005 Dec 1;11(23):8348-57. doi: 10.1158/1078-0432.CCR-05-0841. Clin Cancer Res. 2005. PMID: 16322295

3

Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas.

Vanden Bempt I, Vanhentenrijk V, Drijkoningen M, Wlodarska I, Vandenberghe P, De Wolf-Peeters C. Vanden Bempt I, et al. Histopathology. 2005 Apr;46(4):431-41. doi: 10.1111/j.1365-2559.2005.02112.x. Histopathology. 2005. PMID: 15810955

4

Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.

Schlemmer BO, Sorensen BS, Overgaard J, Olsen KE, Gjerdrum LM, Nexo E. Schlemmer BO, et al. Scand J Clin Lab Invest. 2004;64(5):511-22. doi: 10.1080/00365510410002922. Scand J Clin Lab Invest. 2004. PMID: 15276916

5

HER2 status in breast cancer determined by IHC and FISH: comparison of the results.

Mrozkowiak A, Olszewski WP, Piaścik A, Olszewski WT. Mrozkowiak A, et al. Pol J Pathol. 2004;55(4):165-71. Pol J Pathol. 2004. PMID: 15757204

6

HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.

Pellegrini C, Falleni M, Marchetti A, Cassani B, Miozzo M, Buttitta F, Roncalli M, Coggi G, Bosari S. Pellegrini C, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3645-52. Clin Cancer Res. 2003. PMID: 14506153

7

HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.

Press MF, Finn RS, Cameron D, Di Leo A, Geyer CE, Villalobos IE, Santiago A, Guzman R, Gasparyan A, Ma Y, Danenberg K, Martin AM, Williams L, Oliva C, Stein S, Gagnon R, Arbushites M, Koehler MT. Press MF, et al. Clin Cancer Res. 2008 Dec 1;14(23):7861-70. doi: 10.1158/1078-0432.CCR-08-1056. Clin Cancer Res. 2008. PMID: 19047115

8

Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.

Dressler LG, Berry DA, Broadwater G, Cowan D, Cox K, Griffin S, Miller A, Tse J, Novotny D, Persons DL, Barcos M, Henderson IC, Liu ET, Thor A, Budman D, Muss H, Norton L, Hayes DF. Dressler LG, et al. J Clin Oncol. 2005 Jul 1;23(19):4287-97. doi: 10.1200/JCO.2005.11.012. J Clin Oncol. 2005. PMID: 15994142

9

Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis.

Gjerdrum LM, Sorensen BS, Kjeldsen E, Sorensen FB, Nexo E, Hamilton-Dutoit S. Gjerdrum LM, et al. J Mol Diagn. 2004 Feb;6(1):42-51. doi: 10.1016/S1525-1578(10)60490-4. J Mol Diagn. 2004. PMID: 14736826 Free PMC article.

10

Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.

Santin AD, Bellone S, Van Stedum S, Bushen W, De Las Casas LE, Korourian S, Tian E, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Gynecol Oncol. 2005 Jul;98(1):24-30. doi: 10.1016/j.ygyno.2005.03.041. Gynecol Oncol. 2005. PMID: 15894362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

248 results

Results by year